Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:LENSFNASDAQ:STSSOTCMKTS:TOMDFOTCMKTS:VRSEF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/ASTSSSharps Technology$4.05+2.8%$14.16$3.36▼$5,446.32$219K2.14177,788 shs60,523 shsTOMDFTodos Medical$0.00$0.00▼$0.00$213K0.16218,336 shs44,000 shsVRSEFVerisante Technology$0.00$0.01$0.00▼$0.01$92K19.636,059 shs122,119 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLENSFPresbia0.00%0.00%0.00%0.00%0.00%STSSSharps Technology+2.79%-11.38%-53.77%-96.21%+404,999,900.00%TOMDFTodos Medical0.00%0.00%0.00%0.00%0.00%VRSEFVerisante Technology0.00%0.00%-79.00%-58.00%-8.70%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLENSFPresbiaN/AN/AN/AN/AN/AN/AN/AN/ASTSSSharps Technology1.0038 of 5 stars0.04.00.00.02.01.70.6TOMDFTodos MedicalN/AN/AN/AN/AN/AN/AN/AN/AVRSEFVerisante TechnologyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLENSFPresbia 0.00N/AN/AN/ASTSSSharps Technology 0.00N/AN/AN/ATOMDFTodos Medical 0.00N/AN/AN/AVRSEFVerisante Technology 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLENSFPresbiaN/AN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/A$11.42 per shareN/ATOMDFTodos MedicalN/AN/AN/AN/AN/AN/AVRSEFVerisante TechnologyN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLENSFPresbiaN/AN/A0.00∞N/AN/AN/AN/AN/ASTSSSharps Technology-$9.84M-$1,881.93N/A∞N/AN/A-110.40%-73.60%N/ATOMDFTodos MedicalN/AN/A0.00N/AN/AN/AN/AN/AN/AVRSEFVerisante Technology-$70KN/A0.00∞N/AN/A-3,741.21%-510.28%N/ALatest VRSEF, LENSF, STSS, and TOMDF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025STSSSharps TechnologyN/A$38.62N/A$38.62N/AN/A3/27/2025Q4 2024STSSSharps Technology-$198.00-$861.00-$663.00-$2.87$14.60 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLENSFPresbiaN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ATOMDFTodos MedicalN/AN/AN/AN/AN/AVRSEFVerisante TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLENSFPresbiaN/AN/AN/ASTSSSharps TechnologyN/A1.010.57TOMDFTodos MedicalN/AN/AN/AVRSEFVerisante TechnologyN/A1.041.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLENSFPresbiaN/ASTSSSharps Technology17.17%TOMDFTodos MedicalN/AVRSEFVerisante TechnologyN/AInsider OwnershipCompanyInsider OwnershipLENSFPresbia74.20%STSSSharps Technology1.46%TOMDFTodos MedicalN/AVRSEFVerisante TechnologyN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLENSFPresbia2017.12 millionN/ANot OptionableSTSSSharps Technology354,0005.42 millionNot OptionableTOMDFTodos Medical72.13 billionN/ANot OptionableVRSEFVerisante TechnologyN/A43.94 millionN/ANot OptionableVRSEF, LENSF, STSS, and TOMDF HeadlinesRecent News About These CompaniesVER.H:CA AnalysisApril 11, 2025 | seekingalpha.comVerisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AGMarch 31, 2025 | accessnewswire.comVerisante Technology, Inc. Announces RTO Update:December 18, 2024 | accesswire.comVerisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AGOctober 31, 2024 | accesswire.comVerisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AGAugust 13, 2024 | accesswire.comClosing Bell: Verisante Technology Inc down on Friday (VER-H)August 7, 2024 | theglobeandmail.comClosing Bell: Verisante Technology Inc up on Tuesday (VER-H)July 24, 2024 | theglobeandmail.comVerisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt TransactionMarch 30, 2024 | accesswire.comVerisante: Q4 Earnings SnapshotMarch 29, 2024 | sfgate.comVerisante Technology, Inc. Announces Shares for Debt AgreementsMarch 14, 2024 | accesswire.comVerisante Technology, Inc. Announces 2023 AGM ResultsDecember 21, 2023 | finance.yahoo.comVerisante Technology, Inc. Announces Exchange Approval for Shares for Debt TransactionOctober 5, 2023 | finance.yahoo.comVerisante Technology Inc. Announces Shares for Debt AgreementsSeptember 8, 2023 | finance.yahoo.comVerisante: Q2 Earnings SnapshotAugust 15, 2023 | wtop.comLatest Technology NewsMarch 30, 2023 | prweek.comVerisante Technology, Inc. Announces Exchange Acceptance for Shares for Debt TransactionsNovember 23, 2022 | finance.yahoo.comVerisante: Q3 Earnings SnapshotNovember 18, 2022 | sfgate.comVerisante Technology, Inc.: Verisante Technology Inc. Announces Proposed Shares for Debt TransactionOctober 22, 2022 | finanznachrichten.deVerisante Technology Inc. Announces Proposed Shares for Debt TransactionOctober 19, 2022 | finance.yahoo.comVerisante Technology Inc. Announces Closing Non-Brokered Private PlacementJuly 13, 2022 | apnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVRSEF, LENSF, STSS, and TOMDF Company DescriptionsPresbia OTCMKTS:LENSF$0.02 0.00 (0.00%) As of 10/21/2022Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.Sharps Technology NASDAQ:STSS$4.05 +0.11 (+2.79%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$3.99 -0.06 (-1.48%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.Todos Medical OTCMKTS:TOMDFTodos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.Verisante Technology OTCMKTS:VRSEF$0.0021 0.00 (0.00%) As of 05/21/2025Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
